Results for this period
Interim period (second quarter)1 April 2026 to 30 September 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Strong rental revenue in the Health and Lifestyle Services segment, improved turnover of rental materials, improved profitability in the catering business, higher prescription prices in the Pharmacy Services segment, and the effects of price optimization and the absence of initial costs related to new contracts obtained in the previous fiscal year in the Environmental Services segment contributed to higher profit. On the other hand, drug price revisions, one-time M&A-related expenses, and lower power generation in the solar power business contributed in part to lower profit and revenue.
No applicable items
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 September 2026 |
| Net Sales | 82,111 Millions of yen (YoY +3.9%) |
| Operating profit | 4,920 Millions of yen (YoY +11.5%) |
| Ordinary income | 5,170 Millions of yen (YoY +10.6%) |
| Profit attributable to owners of the parent | 3,351 Millions of yen (YoY +10.2%) |
| Net income per share | ¥108.50 |
| Equity ratio | End of the current fiscal period 73.2 / End of previous period 73 |
| Total assets | 118,822 Millions of yen |
| Net assets | 87,753 Millions of yen |
| Full-year earnings forecast | Net Sales 167,980 Millions of yen (YoY +5.2%) / Operating profit 10,286 Millions of yen (YoY +9.6%) / Ordinary income 10,716 Millions of yen (YoY +6.1%) / Net income 6,866 Millions of yen (YoY +13.1%) |
| Revision to Earnings Forecast | Not disclosed → Net Sales 167,980 / Operating profit 10,286 / Ordinary income 10,716 / Net income 6,866 |
| Annual Dividend Forecast | 68 Yen → 89 Yen |
| Segment revenue | Health and Lifestyle Services 42,667 Millions of yen (YoY +5.1%) / Pharmacy Services 31,999 Millions of yen (YoY +3.5%) / Environmental Services 7,377 Millions of yen (YoY -0.7%) |
| Segment profit | Health and Lifestyle Services 4,699 Millions of yen (YoY +12.8%) / Pharmacy Services 893 Millions of yen (YoY -7.1%) / Environmental Services 768 Millions of yen (YoY +9.9%) |
| Impairment loss | ¥24 million (assets subject to impairment: Not disclosed) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on Sale of Investment Securities 22 Millions of yen / Extraordinary loss Loss on disposal of fixed assets 8 Millions of yen, Impairment loss 24 Millions of yen |
| Disclosure regarding the going concern assumption | No applicable items |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 2 / Name of newly included company 株式会社日晴リネンサプライ, QLCプロデュース株式会社 / Excluded 0 / Name of excluded company Not disclosed |
| Material subsequent events | No applicable items |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Held ( 대상者: Not disclosed) |
| Issued Shares at Period-End | 33,092,146 |
| Treasury Shares at Period-End | 2,190,635 |
| Factors Behind Changes in Business Performance | Strong rental revenue in the Health and Lifestyle Services segment, improved turnover of rental materials, improved profitability in the catering business, higher prescription prices in the Pharmacy Services segment, and the effects of price optimization and the absence of initial costs related to new contracts obtained in the previous fiscal year in the Environmental Services segment contributed to higher profit. On the other hand, drug price revisions, one-time M&A-related expenses, and lower power generation in the solar power business contributed in part to lower profit and revenue. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Health and Lifestyle Services segment, strong rental revenue, improved turnover of rental materials, and improved profitability in the catering business contributed to results. In the Pharmacy Services segment, prescription prices increased, but drug price revisions and one-time M&A-related expenses weighed on profit. In the Environmental Services segment, the effects of price optimization and the absence of initial costs related to new contracts obtained in the previous fiscal year contributed to profit.